Related Experiment Video
Updated: Oct 25, 2025

Measuring RAN Peptide Toxicity in C. elegans
Published on: April 30, 2020
Acute Necrotizing Encephalopathy: 2 Case Reports on RANBP2 Mutation
Molly Hartley1, Anjana Sinha1, Ashutosh Kumar2
1Penn State College of Medicine, Hershey, PA, USA.
Abstract:
Infection-induced acute encephalopathy 3 (IIAE3) is an autosomal dominant disease resulting from a pathogenic variant in the RANBP2 gene. IIAE3 results in the susceptibility to the recurrence of acute necrotizing encephalopathy (ANE1) which presents as bilateral symmetric thalamic, midbrain and/or hindbrain lesions that typically develops within 1-4 days post-acute viral infection, commonly occurring before age 6.1-6 These case reports highlight a retrospective analysis of clinical data and radiographic studies on 2 ANE1 cases from our institution. The novel p.Leu450Phe variant of the RANBP2 gene was analyzed using in silico algorithms (PolyPhen-2, SIFT, Mutationtaster) which suggests the p.Leu450Phe variant is probably deleterious.7 An expansion of documented ANE1 case presentations and clinically significant RANBP2 gene mutations has the potential to improve long term outcomes if more informed therapeutic decision making can be achieved.
Insights
Infection-induced acute encephalopathy 3 (IIAE3) is linked to RANBP2 gene variants. A novel p.Leu450Phe variant suggests a probable cause for recurrent acute necrotizing encephalopathy (ANE1) in children.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Infection-induced acute encephalopathy 3 (IIAE3) is an autosomal dominant disorder.
- It is caused by pathogenic variants in the RANBP2 gene.
- IIAE3 confers susceptibility to recurrent acute necrotizing encephalopathy (ANE1).
Observation:
- This study presents a retrospective analysis of 2 ANE1 cases.
- Clinical data and radiographic studies were examined.
- A novel p.Leu450Phe variant in the RANBP2 gene was identified.
Findings:
- In silico analysis (PolyPhen-2, SIFT, Mutationtaster) suggests the p.Leu450Phe variant is likely deleterious.
- The identified variant may contribute to the pathogenesis of ANE1.
Implications:
- Expanding the understanding of ANE1 presentations and RANBP2 mutations is crucial.
- Informed therapeutic decisions can potentially improve long-term outcomes for patients.
- Further research into RANBP2 variants and ANE1 is warranted.
More Related Videos
07:30A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018